ライフサイエンスコーパス: quality of life

1 less frequent angina and better function and quality of life).

2 hereby maintaining health, productivity, and quality of life.

3 erance in a variety of conditions that limit quality of life.

4 ect that can severely impact an individual's quality of life.

5 ities and substantially diminishes patients' quality of life.

6 is associated with improved patient-reported quality of life.

7 nsiderable compromise of visual function and quality of life.

8 differences in urinary or bowel function and quality of life.

9 ours, and relationship to asthma control and quality of life.

10 motivated only by an expectation of improved quality of life.

11 tly worse physical and mental health-related quality of life.

12 unnecessary surgeries that degrade patients' quality of life.

13 usly is threatening human health and overall quality of life.

14 ith positive impacts on symptoms and overall quality of life.

15 rder that can seriously impact the patient's quality of life.

16 gth, leading to physical incapacity and poor quality of life.

17 work; and physical and mental health-related quality of life.

18 ger cohort studies incorporating measures of quality of life.

19 RD associated with significant impairment of quality of life.

20 n shown to negatively impact an individual's quality of life.

21 rove their clinical outcomes, but also their quality of life.

22 oving responsiveness to cancer treatment and quality of life.

23 e experience symptoms that negatively impact Quality of Life.

24 rofile of dumping syndrome and its effect on quality of life.

25 heterogeneous diseases with a high impact at quality of life.

26 alleviate symptoms and improve the patient's quality of life.

27 on of new treatments for improving patients' quality of life.

28 ncer patients and seriously compromise their quality of life.

29 which has significant impacts to a patient's quality of life.

30 chemically and radiologically and changes in quality of life.

31 mon among women and contributes to decreased quality of life.

32 tantial savings and improvement in patients' quality of life.

33 l acuity and substantially improve patients' quality of life.

34 equate therapy so as to improve symptoms and quality of life.

35 mately leading to disability and decrease of quality of life.

36 isease-free or recurrence-free survival, and quality of life.

37 f myopic patients with respect to vision and quality of life.

38 cancer survivors' healthcare experiences and quality of life.

39 evels were strongly associated with a better quality of life.

40 , but there was no significant difference in quality of life.

41 pain conditions, which further alters their quality of life.

42 uncontrolled CRS patients, clearly impacting quality of life.

43 ength of hospital stay, and patient-reported quality of life.

44 significantly affects sensory perception and quality of life.

45 vements for inhaler technique, adherence and quality of life.

46 intubation, but no significant difference in quality of life.

47 terations that must be addressed to optimize quality of life.

48 of amblyopic children also experience lower quality of life.

49 ssess the effect of stigma on health-related quality of life.

50 significant health care burden and impaired quality of life.

51 a substantial negative impact on a patient's quality of life.

52 ion therapy to improve metabolic control and quality of life.

53 re resource use and decreased health-related quality of life.

54 l transplant are living longer with a better quality of life.

55 The consequences were (1) a good quality of life, (2) preserving dignity, and (3) coping

56 ponse (92% versus 65%, P=0.023) and improved quality of life (-31.0+/-29.7 versus -15.7+/-22.1, P=0.0

57 0%, respectively) and overall health-related quality of life (48% and 58%, respectively) as well as i

58 n); and 2) self-rated health on the European Quality of Life-5 Dimensions-5 Level visual analogue sca

59 d good health-related quality of life with a Quality of Life after Brain Injury total score greater t

60 t association between delirium and decreased quality of life after hospital discharge in young childr

61 in the outcome after aneurysm treatment and quality of life after SAH influenced the preferred scree

62 n Heart Failure), we analyzed differences in quality of life among men and women with heart failure a

63 er medicine use, and impaired health-related quality of life and ability to work.

64 rders such as PTSD, that result in decreased quality of life and adverse outcomes, including addictio

65 mastectomy breast reconstruction can restore quality of life and body image, its morbidity remains su

66 ith age, injury, and disease; it affects the quality of life and complicates treatment.

67 n be asymptomatic or result in impairment in quality of life and end-stage, severe, and/or life-threa

68 s between visual acuity (VA) and eye-related quality of life and functional vision in children, acros

69 DED affects patients' quality of life and leads eventually to decrease of prod

70 nagement of irAEs is important in optimizing quality of life and long-term outcomes.

71 ion option, these young patients face a poor quality of life and overall survival.

72 The positive clinical impact of improved quality of life and reduced health care utilization may

73 mproves exercise capacity and health-related quality of life and reduces readmissions.

74 jects with FBD had significant reductions in quality of life and reported more gastrointestinal docto

75 energy metabolism, physical performance, or quality of life and sleep between treatment arms.

76 ues, preferences, and goals, with a focus on quality of life and symptom management.

77 n empathetic approach is key and can improve quality of life and symptoms, and reduce health-care exp

78 ssociated with small gains in health-related quality of life and the lowest overall costs.

79 of oncoplastic breast-conserving surgery on quality of life and the optimal type and timing of recon

80 with and without CRT as were improvements in quality-of-life and exercise capacity.

81 sal eosinophilia, chronic symptoms, impaired quality of life, and a lack of adequate treatments.

82 eration addresses patient goals and improves quality of life, and additionally reduces extremity volu

83 life-threatening, greatly decrease patient's quality of life, and are a substantial burden on the hea

84 The model reproduced 30-month survival, quality of life, and cardiovascular hospitalization rate

85 me measures of health status, health-related quality of life, and depression.

86 study will provide clinical, health-related quality of life, and economic outcomes to inform future

87 have a substantial impact on patient health, quality of life, and healthcare costs.

88 sease associated with substantial effects on quality of life, and its clinical management is difficul

89 ressal of symptom management, health-related quality of life, and other patient-reported outcomes acr

90 tion, chemotherapy interruptions and delays, quality of life, and progression-free survival (PFS) and

91 ssure, plasma markers, physical performance, quality of life, and quality of sleep.

92 ition to cow's milk proteins, health-related quality of life, and safety.

93 h priorities to improve patient outcomes and quality of life are developing new, more rapid diagnosti

94 erienced a greater symptom burden and poorer quality of life as compared with men.

95 ent from baseline to week 12 in itch-related quality of life as measured by the 5-D itch scale and th

96 important effect on lifespan, healthspan and quality of life as patients age worldwide, highlighting

97 The primary outcome was fibroid-related quality of life, as assessed by the score on the health-

98 PA classification; clinical characteristics; quality of life, as measured by the National Eye Institu

99 nary symptoms, sexual function and impact on quality of life, as well as measurement of prostate volu

100 ed cellulitis-related hospital admission and quality-of-life assessments.

101 ctory Short Form-36 evaluated health-related quality of life at 1-year follow-up.

102 went myomectomy had a better fibroid-related quality of life at 2 years than those who underwent uter

103 physical function- and mental health-related quality of life at 2-3 months and 6 months post-hospital

104 a at 7, 30, 90, and 180 days; health-related quality of life at 30, 90, and 180 days; all-cause morta

105 s no statistically significant difference in quality of life at 6 months.

106 ent, serious deterioration of health-related quality of life at month 3.

107 ospital admissions, need for intubation, and quality of life at the longest follow-up.

108 Change from baseline health-related quality of life at the month 3 follow-up was assessed by

109 100, with higher scores indicating a better quality of life) at 2 years; adjustment was made for the

110 s' long-term outcomes, healthcare costs, and quality of life based on their characteristics at entry.

111 and cognitive functioning, as well as their quality of life before ICU admission.

112 mplete the 26-item World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire (items

113 ear future, not only through improvements in quality of life but also in terms of survival.

114 small improvements in sexual functioning and quality of life but little to no benefit for other commo

115 bidities, a shortened lifespan, and a poorer quality of life, but epidemiological studies characteriz

116 Chemicals have improved our quality of life, but the resulting environmental polluti

117 scular hospitalizations and slows decline in quality of life compared with placebo.

118 conomic issues impacting disease control and quality of life; (d) enrolling the family in assisting A

119 -term risks of recurrent stroke, disability, quality of life, dementia and hospital care costs strati

120 ors demonstrated significant, health-related quality of life deterioration from baseline that persist

121 th and/or persistent, serious health-related quality of life deterioration were candidates for multiv

122 Mean change in patients' quality of life did not differ between intervention and

123 ut tended to improve with time, while mental quality of life did not differ significantly from the ge

124 blem rating of hot flushes and subdomains of quality of life did not improve.

125 and psychological symptoms, life impact (ie, quality of life, disability and general functioning) and

126 ncluded tolerability, ocular surface health, quality of life, disease progression, and cost-effective

127 ging and clinical outcome assessments (pain, quality of life, disfigurement, and function) were perfo

128 related to major CIED infections: mortality, quality of life, disruption of CIED therapy, healthcare

129 assessed by the score on the health-related quality-of-life domain of the Uterine Fibroid Symptom an

130 cores on a 0 to 100 scale-and health-related quality of life-EQ-5D-5L on a 0 to 1 scale-using linear

131 by radiation-induced fibrosis and reduce the quality of life for cancer survivors.

132 -induced bone loss, significantly increasing quality of life for cancer survivors.

133 al to provide a better prognosis and overall quality of life for GBM patients.

134 tment for peanut allergy and may improve the quality of life for many peanut allergic children.

135 as the potential to dramatically improve the quality of life for patients on blood thinners and, in t

136 e Fontan procedure has improved survival and quality of life for patients with single ventricle physi

137 ving chemotherapy and a permanently impaired quality of life for patients.

138 o effectively ameliorate LID and improve the quality of life for PD patients.

139 ne function could enhance health and improve quality of life for people with type 1 and type 2 diabet

140 econdary outcomes were falls, health-related quality of life, frailty, and a parallel economic evalua

141 hemotherapy) in QLQ-C30 global health status/quality of life (GHS/QOL) score, and time to deteriorati

142 lysis showed the surgical group had a higher quality of life (GIQLI) score than the conservative grou

143 Quality of life has been proposed as the fourth 90 to co

144 CIED infections severely impact mortality, quality of life, healthcare utilization, and cost in the

145 r an ICU admission are associated with lower quality of life, higher mortality, and resource utilizat

146 ic-clonic seizures are associated with lower quality of life, higher risk of seizure-related injuries

147 psychosocial functioning, and health-related quality of life; however, physical manifestations of CSD

148 essive symptoms, and impaired health-related quality of life (HRQL) are common among patients with li

149 living with PA on children's health-related quality of life (HRQL), correlations between PA severity

150 of infections and long-term, health-related quality-of-life (HRQL) improvements in patients with hep

151 Many important details of health-related quality of life (HRQoL) after diagnosis and treatment of

152 of the long-term sequelae and health-related quality of life (HRQoL) associated with LD in North Amer

153 of diagnosis and treatment on health-related quality of life (HRQOL) at 2 years.

154 ic conditions that may impact health-related quality of life (HRQOL) despite HF therapy.

155 compare short- and long-term health-related quality of life (HRQOL) following HMIE and OE within a r

156 body composition at midlife, health-related quality of life (HRQoL) in old age, and longevity are, h

157 rain stimulation (GPi DBS) on health-related quality of life (HRQoL) in patients with inherited or id

158 The primary outcome was health-related quality of life (HRQOL) measured by FACT-BMT score at da

159 as well as questionnaires for health-related quality of life (HRQoL), GINA and the Asthma Control Tes

160 s (CRSwNP) negatively affects health-related quality of life (HRQoL).

161 lation (AF) adversely impacts health-related quality of life (hrQoL).

162 127) exhibited severe CRSwNP and substantial quality of life impairment evidenced by a mean NPS highe

163 dentified across studies: (a) Health-related quality of life-impairment was associated with poor dise

164 Quality of life improved in the 1500-mg arm at 12 weeks

165 Quality of life improved more between baseline and week

166 6-month follow-up which also correlated with quality of life improvements.

167 ulty was consistently associated with poorer quality of life in all domains (OR range: 2.9-9.7).

168 velopment of beneficial therapies to enhance quality of life in individuals who suffer prolonged seiz

169 in this disease could significantly improve quality of life in patients with CP.

170 Palliative care improves quality of life in patients with heart failure.

171 ecompression can reduce symptoms and improve quality of life in patients with malignant biliary obstr

172 pment of interventions to improve survivors' quality of life in the context of healthcare.

173 as also associated with significantly higher quality of life in vasomotor and other physical dimensio

174 llow-up, as measured by the Gastrointestinal Quality of Life Index (GIQLI).

175 parent proxy-report employing the Pediatric Quality of Life Inventory or the Stein-Jessop Functional

176 omy than for open surgery, and postoperative quality of life is similar between the treatment groups,

177 mary determinant of prognosis, mortality and quality of life, is diminished in patients with chronic

178 inactive control group at posttreatment for quality of life (k = 6; n = 401; SMD = 0.33, 95% CI -0.0

179 omposite score (primary efficacy end point), quality of life, LV structural remodeling ( EF >5% and E

180 Overall quality of life (LYMQOL) improved by a mean of 33%.

181 ventions demonstrated significantly improved quality of life, management of asthma symptoms, controll

182 D -3.08; 95% CI -4.41 to -1.75) and improves quality of life (MD -4.80; 95% CI -5.55 to -4.06).

183 core after FMT, 3.07; range, 0.79-4.23), and quality of life (mean increase, 16%; median score before

184 ; and/or the EuroQol-5D-5L, a health-related quality of life measure (physical function).

185 defined as a respiratory PedsQL, a pediatric quality of life measure, greater than or equal to 5 or a

186 s, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Heal

187 expiratory volume in 1 second (FEV(1) ) and quality of life measures, and it was generally well tole

188 We found no effect on health-related quality of life measures, perceived thirst or xerostomia

189 ded the change from baseline in itch-related quality-of-life measures, the percentage of patients wit

190 e trajectory of mortality and health-related quality of life morbidity for children encountering comm

191 aims to alleviate suffering and improve the quality of life of children with serious disease and inc

192 n foods would greatly improve the health and quality of life of food allergy sufferers.

193 rophies, which may substantially improve the quality of life of patients with these disorders.

194 e a significant impact for broadly improving quality of life of SCI individuals.

195 l skin disorder, significantly impacting the quality of life of suffering patients.

196 s the mobility, social participation and the quality of life of the people.

197 ecause seizures can significantly impact the quality of life of XLID patients, the present data sugge

198 report the results of a secondary endpoint, quality of life, of the LACC trial.

199 Main outcome measures were quality of life (operationalised as European Organisatio

200 d heart performance, symptoms, and worsening quality of life or life expectancy.

201 al (OR=2.1), functional (OR=2.9) and overall quality of life (OR=2.0).

202 lowing outcomes: glycemic change, mortality, quality of life, or cost-effectiveness.

203 ion process quality, shared decision-making, quality of life, or preferences (all ps > 0.05).

204 The recurring associations between quality of life outcomes and continuity of care and soci

205 e UKSTAR trial was to compare functional and quality-of-life outcomes and resource use in patients tr

206 Most quality-of-life outcomes did not differ between the two

207 Here, we report the quality-of-life outcomes from the CARD study.

208 act on RV remodeling, functional status, and quality of life over the long-term remains unclear.

209 four Specific Outcomes (Child Health-Related Quality of Life, Pain, Survival, and Communication).

210 in choosing a management approach, predicted quality of life, predicted life expectancy, patient pref

211 NIFICANCE STATEMENT Unabated seizures reduce quality of life, promote the development of epilepsy, an

212 worse at all time points, with worse global quality of life (QOL) (MD -10, 95% CI -18 to -2) and dys

213 Little is known about quality of life (QoL) and life satisfaction (LS) of trea

214 whether midostaurin improves health-related quality of life (QOL) and MC mediator-related symptoms i

215 gue coating, whereas secondary outcomes were quality of life (QOL) and treatment safety.

216 tearing, itching, and mucous discharge), and quality of life (QoL) assessed by QUICK questionnaire ob

217 RP), the diversity of the faecal microbiota, quality of life (QoL) assessments and the incidence of u

218 Quality of life (QOL) had declined due to severe pruritu

219 with respect to both symptom alleviation and quality of life (QoL) in major depressive disorder (MDD)

220 tion to the severity of neuropathic pain and quality of life (QoL) in patients with and without painf

221 tionnaire-Lung Cancer 13 (QLQ-LC13) assesses quality of life (QOL) in patients with lung cancer and w

222 en known risk factors such as depression and quality of life (QOL) in stroke survivor-care partner dy

223 The quality of life (QOL) of both arms was broadly similar a

224 otherapy (OIT) for food allergy improves the quality of life (QOL) of children from parental perspect

225 ecommended therapies and their impact on the quality of life (QoL) of chronic urticaria (CU) patients

226 t use), disease-generic and disease-specific quality of life (QOL), and symptoms, with estimates of Q

227 rom a high symptom burden and a deteriorated quality of life (QOL), with uncertain prognosis and limi

228 ) on HIV suppression, immune activation, and quality of life (QoL).

229 ogression-free survival (PFS), toxicity, and quality of life (QOL).

230 eanut allergy (PA) is associated with marked quality-of-life (QoL) impairment.

231 eath-ligand 1 (PD-L1) status, and on-therapy quality-of-life (QOL) metrics using the Functional Asses

232 Quality-of-Life (QoL) scores were correlated from the th

233 The Angioedema Quality of Life Questionnaire (AE-QoL) was administered

234 f life was measured using the Infant-Toddler Quality of Life questionnaire at three time points: base

235 ization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30-item and the EuroQ

236 ization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30-item global health

237 urveys (Asthma Control Questionnaire, Asthma Quality of Life Questionnaire) and 1:1 semi-structured i

238 The Food Allergy Quality of Life Questionnaire-Child Form (FAQLQ-CF) was

239 for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13)

240 Patients completed the IBS-specific quality of life questionnaire.

241 BS) and constipation questions, and the SF-8 quality of life questionnaire.

242 isation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30 (QLQ-C30) and Lung

243 for Research and Treatment of Cancer [EORTC] Quality of life Questionnaires, Breast cancer module [QL

244 estionnaire including generic health-related quality of life questionnaires.

245 otion discrimination performance, and visual quality-of-life questionnaires.

246 1) and were negatively correlated with worse quality of life (r = -0.48, P < .001).

247 1) and were positively correlated with worse quality of life (r = 0.45 and r = 0.33, respectively; P

248 ted through correlations with health-related quality of life (r = 0.698).

249 s evidenced by the International Society for Quality of Life Research score (median score in studies

250 lifestyle questionnaire and the Professional Quality of Life Scale were used in this study.

251 The World Health Organization Quality of Life Scale-Brief Version general score improv

252 sion Rating Scale, World Health Organization Quality of Life Scale-Brief Version, Global Assessment o

253 ement was as follows: IPSS, 16 points +/- 7; quality-of-life score, 4 points +/- 1; prostatic volume

254 At follow-up, Infant-Toddler Quality of Life scores for the PICU cohort overall were

255 try Disability Index, back and leg pain, and quality-of-life scores at 6 weeks, 3 months, 6 months, a

256 No significant differences were seen in quality-of-life scores or lung function between the trea

257 mprovements in Atrial Fibrillation Effect on Quality-of-Life scores were significantly better among p

258 ared with the control group for self-esteem, quality of life, self-efficacy, coping strategies, mood

259 ng (Cognitive Failure Questionnaire-14), and quality of life (Short Form-36) before ICU admission.

260 ced urinary sodium without adverse safety or quality of life signals, a larger trial, with modificati

261 roved walking performance and health-related quality of life similarly compared to other arterial dis

262 focus on PG-specific outcome measures and PG quality-of-life studies.

263 (52.2%) had completed paired health-related quality of life surveys.

264 associated with multiple outcomes, including quality of life, symptoms of depression and anxiety, ill

265 lysis, clinical and hemodynamic improvement, quality of life, target limb amputation, and all-cause m

266 their own personal goals and determinants of quality of life that are independent of a particular gly

267 ing reached in many contexts, health-related quality of life, the so-called fourth 90, warrants speci

268 ditional value driven from an improvement in quality of life through clinical superiority.

269 Despite severe repercussions on quality of life treatment options remain limited.

270 Quality of life typically improves after successful inte

271 fe domain of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire (scores range fr

272 The primary end point was patient-reported quality of life using the 36-Item Short Form Health Surv

273 entally sensitive measures of vision-related quality of life (VQoL) are needed to capture age-specifi

274 have a detrimental impact on vision-related quality of life (VRQoL), but it is still unclear how thi

275 Quality of life was a prespecified secondary outcome of

276 was disease-free survival at 4.5 years, and quality of life was a secondary endpoint.

277 Patient-reported quality of life was assessed prospectively using PROMIS

278 low to moderate in quality, the evidence on quality of life was insufficient, and the analyses for s

279 Vision-related quality of life was measured using Rasch-transformed sco

280 Quality of life was measured using the Infant-Toddler Qu

281 Quality of life was reduced (P=0.004) and did not normal

282 , overall physical and mental health-related quality of life was significantly reduced among firearm

283 eal membrane oxygenation survivors' physical quality of life was worse than population norms but tend

284 ges in RV remodeling, functional status, and quality of life, we assessed patients with acute submass

285 ancer and the opportunity for improvement in quality of life, we suggest further research directions

286 Tremor and quality of life were assessed before, 1 month after, and

287 y palliative care interventions; results for quality of life were generally nonsignificant or showed

288 Gut symptoms and health-related quality of life were measured using validated questionna

289 ntestinal (GI) symptoms, dietary intake, and quality of life were measured.

290 Clinically meaningful improvements in quality of life were observed in all patients.

291 systolic function, functional capacity, and quality of life when compared with placebo.

292 e reassured that cabazitaxel will not reduce quality of life when compared with treatment with a seco

293 S has profound negative effects on patients' quality of life, which often culminate in social withdra

294 h response rates, low toxicity, and improved quality of life with (177)Lu-PSMA radioligand therapy.

295 ASSESS was responsive to changes in quality of life with a minimally important difference of

296 ectomy patients reported good health-related quality of life with a Quality of Life after Brain Injur

297 essed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (S

298 s or tooth decay (caries), affect health and quality of life, with associated costs to society(3).

299 being associated with near-maximal levels of quality of life, with minimal impairment.

300 ic inhibitor enasidenib, leading to improved quality of life without a reduction in AML disease burde